Josephine Kay Barry, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Mile 266 1/2 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 Fax: 907-895-2020 |
Patricia C Gilson Counselor Medicare: Not Enrolled in Medicare Practice Location: Mile, 266 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 |
Victor Downing Counselor Medicare: Not Enrolled in Medicare Practice Location: Mile 266.5 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 Fax: 907-895-2020 |
Bryanna Lynn Wimberly Counselor Medicare: Not Enrolled in Medicare Practice Location: Mile 266.5 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 |
Emily Jane Maclee Counselor Medicare: Not Enrolled in Medicare Practice Location: Mile 266.5 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 Fax: 907-895-2020 |
Laurie Litzenberger, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 266.5 Richardson Hwy, Delta Junction, AK 99737 Phone: 907-803-7022 Fax: 907-895-2020 |
News Archive
Antares Pharma, Inc. and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced transdermal delivery) gel system. Based on this successful data, the two parties continue to expect to partner with a worldwide or regional pharmaceutical company in order to commercialize this novel contraceptive gel.
The propensity to overeat may, in part, be a function of the satisfaction derived from eating. A new study in the Journal of the Academy of Nutrition and Dietetics, published by Elsevier, found no significant difference in taste perceptions between participants of normal weight and those who were overweight.
Gut bacteria are tiny but may play an outsized role not only in the host animal's digestive health, but in their overall well-being.
Virginia Commonwealth University Massey Cancer Center researcher Steven Grant, M.D., and a team of VCU Massey researchers have uncovered the mechanism by which leukemia cells trigger a protective response when exposed to a class of cancer-killing agents known as histone deacetylase inhibitors (HDACIs).
› Verified 8 days ago